Best TouchPODCAST Podcasts (2025)

1
RET-positive NSCLC: Translating insights into targeted approaches 14:36

16d ago14:36

14:36

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an independent medical educati…

1
Advances in dry eye disease: From diagnosis to new treatment targets 37:43

23d ago37:43

37:43

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted ap…

1
Recent advances in the care of patients with geographic atrophy: Bringing new and emerging therapies into focus 35:33

25d ago35:33

35:33

touchIN CONVERSATION for touchOPHTHALMOLOGY Listen to two experts in geographic atrophy (GA) discuss recent advances in the care of patients. They explore the importance of early identification of GA and how this can be achieved, examine the potential impact of new and emerging therapies for GA, and highlight key practical considerations for monito…

1
The potential of BTKi therapies in delaying MS progression 13:32

1M ago13:32

13:32

touchEXPERT FOCUS for touchNEUROLOGY Join Prof. Montalban as he shares expert insights into the pathophysiology of progressive MS and the rationale for targeting BTK inhibitors. He reviews emerging clinical data supporting the use of BTK inhibitors and discusses how they may fit into the evolving treatment landscape. In this context, Prof. Montalba…

1
Reducing burden of disease in gMG: Exploring the role of FcRn inhibitors 30:27

1M ago30:27

30:27

touchPANEL DISCUSSION for touchNEUROLOGY Listen to two expert neurologists and a neurology nurse as they explore the role of neonatal Fc receptor (FcRn) inhibitors in improving the burden of disease in patients with generalized myasthenia gravis. The faculty will consider how the burden of disease and treatment in patients with generalized myasthen…

1
MDT perspectives on why and how to implement continuous glucose monitoring in T2D 13:26

1M ago13:26

13:26

Listen to key experts from a multidisciplinary team review and discuss why and how to implement continuous glucose monitoring in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Nurse specialist: Ms. Lori Berard Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This ac…

1
MDT perspectives on evolving options for insulin therapy 10:05

1M ago10:05

10:05

Listen to key experts from a multidisciplinary team review and discuss evolving options for insulin therapy. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nordisk. This activity is…

1
MDT perspectives on understanding clinical inertia in T2D 12:14

1M ago12:14

12:14

Listen to key experts from a multidisciplinary team review and discuss clinical inertia in T2D. The multidisciplinary team Endocrinologist: Prof Tina Vilsbøll Primary Care Physician: Dr Gihane Zarifa Patient advocate: Mr. Ostap Soroka This touchPODCAST is for HCPs only. This activity is funded by an independent medical education grant from Novo Nor…

1
Navigating the clinical impact of TROP2-targeting in NSCLC 55:41

1M ago55:41

55:41

touchSYMPOSIUM for touchONCOLOGY Listen to this touchSYMPOSIUM recorded live in March 2025 at the The European Lung Cancer Congress in Paris, France. Symposium chair Prof. Marina Garassino is joined by Prof. Jarushka Naidoo and Prof. David Planchard to explore the evolving role of TROP2-targeted ADCs in NSCLC. Session 1: Prof. Marina Garassino high…

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchNEUROLOGY 33:43

2M ago33:43

33:43

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management of al…

1
Integrating treatment advances for alpha-mannosidosis into effective MDT care - touchENDOCRINOLOGY 33:45

2M ago33:45

33:45

touchPANEL DISCUSSION for touchENDOCRINOLOGY Listen to a panel of world-leading experts in lysosomal storage disorders explore treatment needs along the lifespan of people living with alpha-mannosidosis, discuss the evolving treatment landscape, and finally, reflect on how treatment advances may be integrated into the multidisciplinary management o…

1
The evolving standard of care for advanced/recurrent endometrial cancer: A practice-focused discussion of immunotherapy 38:58

2M ago38:58

38:58

touchIN CONVERSATION for touchONCOLOGY Listen to two expert gynaecologic oncology specialists discuss the evolving role of immunotherapy in the treatment of advanced/recurrent endometrial cancer. They explore how immune checkpoint inhibitors are reshaping standards of care across lines of therapy, highlight key practical considerations for optimizi…

1
Tailoring treatment in myelofibrosis: Addressing anaemia and thrombocytopenia 35:35

2M ago35:35

35:35

touchPANEL DISCUSSION for touchHAEMATOLOGY Listen to three experts as they explore the burden of myelofibrosis and anaemia and/or thrombocytopenia, discuss targeted treatment strategies and how to maximize benefits for patients. The experts Prof. Haifa Kathrin Al-Ali – University Hospital of Halle, Halle (Saale), Germany Prof. Jean-Jacques Kiladjia…

1
Video 3: MDT perspectives on identifying and managing key ADC treatment toxicities in patients with metastatic breast cancer 11:54

2M ago11:54

11:54

Listen to key experts from a multidisciplinary team consider the strategies to avoid, mitigate, identify and effectively manage side effects associated with ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, E…

1
Video 2: MDT perspectives on communicating ADC treatment toxicities to patients with metastatic breast cancer 13:03

2M ago13:03

13:03

Listen to key experts from a multidisciplinary team discuss effective strategies for communicating the potential side effects associated with ADC treatment to patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory W…

1
Video 1: MDT perspectives on the safety profiles of current and emerging ADCs in metastatic breast cancer 11:59

2M ago11:59

11:59

Listen to key experts from a multidisciplinary team review and discuss the safety profiles of current and emerging ADCs in patients with metastatic breast cancer. The multidisciplinary team Medical oncologist: Dr Véronique Diéras, Centre Eugène Marquis, Rennes, France Nurse practitioner: Dr Kayla Freeman, Emory Winship Cancer Institute, Atlanta, GA…

1
Precision in practice: Adopting emerging therapies for retinal diseases to reduce burden of disease 19:12

2M ago19:12

19:12

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to retina specialist Prof. Peter Kaiser answer a series of questions on the current clinical landscape for neovascular age-related macular degeneration and diabetic macular oedema, share his perspective on how newly available treatments are influencing the existing standard of care and provide guidanc…

1
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:26

2M ago1:06:26

1:06:26

touchCONGRESS for touchCARDIO Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Prof. B…

1
Expanding horizons for patients with Pompe disease: Using data to guide clinical practice 1:06:27

2M ago1:06:27

1:06:27

touchCONGRESS for touchENDOCRINOLOGY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and …

1
Expanding horizons for patients with Pompe disease Using data to guide clinical practice 1:06:27

2M ago1:06:27

1:06:27

touchCONGRESS for touchRESPIRATORY Listen to world-leading expert Prof. Tahseen Mozaffar as he reviews key data on current and emerging treatment options for Pompe disease presented at the 29th Annual Congress of the World Muscle Society, and 21st Annual WORLDSymposium 2025. Prof. Mozaffar is then joined by fellow experts Dr Jennifer L Cohen and Pr…

1
MDT perspectives on the importance of patient engagement in PARPi use - Video 3 13:21

3M ago13:21

13:21

touchMDT for touchONCOLOGY Listen to experts Dr Alicia Morgans, Dr Grace Cullen, and patient advocate, Mr Tony Collier, discuss the importance and practicalities of engaging patients in their care and hear insights from the perspective of a patient advocate in relation to the use of PARP inhibitors. The multidisciplinary team and patient advocate: …

1
MDT perspectives on understanding precision medicine to guide PARPi use in mCRPC - Video 2 13:45

3M ago13:45

13:45

touchMDT for touchONCOLOGY Somatic and germline testing are key in managing metastatic castration-resistant prostate cancer (mCRPC). Listen as Prof. Albrecht Stenzinger shares his perspectives as a pathologist with Dr Alicia Morgan and Dr Grace Cullen. The multidisciplinary team: Medical oncologist – Dr Alicia Morgans Dana-Farber Cancer Institute, …

1
MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC - Video 1 13:44

3M ago13:44

13:44

touchMDT for touchONCOLOGY MDT perspectives on unlocking the data on PARPi to support shared decision-making in mCRPC Experts Dr Alicia Morgans and Dr Grace Cullen share insights into using evidence to guide practice and shared decision-making with patients with metastatic castration-resistant prostate cancer (mCRPC). The multidisciplinary team: Me…

1
The next frontier in managing obesity and T2D: The role of novel combinations for touchENDOCRINOLOGY 32:02

3M ago32:02

32:02

touchEXPERT OPINIONS for touchENDOCRINOLOGY Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of o…

1
The next frontier in managing obesity and T2D: The role of novel combinations for touchCARDIO 32:01

3M ago32:01

32:01

touchEXPERT OPINIONS for touchCARDIO Listen to three experts discuss the rationale behind glucagon-like peptide-1 (GLP-1)-based combination therapies and review the latest clinical evidence for these novel combinations. The expert faculty will provide their insights on what these combination treatments may mean for the future management of obesity …

1
From clinical trials to clinical practice: Applying CDK4/6 inhibitors in HR+/HER2– early breast cancer 36:50

3M ago36:50

36:50

touchEXPERT OPINIONS for touchONCOLOGY Listen to three experts in breast cancer as they provide insights into the current guideline recommendations for the use of targeted therapy in patients with HR+/HER2– early breast cancer, evaluate the latest data for CDK4/6 inhibitors in this patient population and consider how to maximize the potential of th…

1
Cervical cancer prevention and beyond: Optimizing HPV vaccine uptake in all eligible individuals 36:26

3M ago36:26

36:26

touchIN CONVERSATION for touchINFECTIOUS DISEASES Listen to a paediatrician specializing in adolescent medicine and a general practitioner specializing in sexual health as they address healthcare professionals' questions on HPV vaccination. They provide insights into the burden of HPV-related oncological and non-oncological diseases, appropriate va…

1
Looking to the future in the treatment of steroid-refractory chronic GvHD 16:31

3M ago16:31

16:31

touchFOCUS for touchHAEMATOLOGY In this concise interview, Dr Corey Cutler discusses unmet needs in steroid-refractory chronic GvHD and how they may be addressed with new and emerging therapies. The expert: Dr Corey Cutler - Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs outside the UK. This activity is funded by an ind…

1
Updates in BCMA-directed therapies in multiple myeloma from ASH 2024 55:57

4M ago55:57

55:57

touchCONGRESS for ONCOLOGY Multiple myeloma expert Prof. Katja Weisel summarizes key data for BCMA-targeted agents in multiple myeloma presented at the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition. Prof. Weisel is then joined by fellow experts Dr Nisha Joseph and Prof. Roman Hájek to discuss the potential implications of …

1
RAS mutations and personalized cancer care: Targeting the future 31:02

4M ago31:02

31:02

touchEXPERT OPINIONS for touchONCOLOGY Listen to a medical oncologist, a pancreatic cancer specialist and a lung cancer specialist discuss the role of RAS mutations in solid tumours, notably pancreatic cancer and NSCLC, and how they may be therapeutically targeted to improve patient outcomes. The experts Dr David S Hong, The University of Texas MD …

1
What’s new in primary ITP? Key updates from ASH 2024 40:35

4M ago40:35

40:35

touchPANEL DISCUSSION for touchONCOLOGY Listen to three expert haematologists as they explore how immune thrombocytopenia (ITP) is managed today, emerging targeted treatments and the real-world impact of ITP. The faculty share their insights and review the latest data on these topics from the 66th American Society of Hematology Annual Meeting & Exp…

1
Focused insights: Data implications of ADCs in NSCLC treatment 21:54

4M ago21:54

21:54

touchFOCUS for touchRESPIRATORY Listen to Prof. Céline Mascaux, an expert in thoracic oncology, answer a series of questions on the latest efficacy and safety data for ADCs in the treatment of patients with NSCLC in the first- and second-line setting, and place these data in the context of current standards of care. She also considers how these dat…

1
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchONCOLOGY 1:20:58

4M ago1:20:58

1:20:58

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia…

1
Collaboration in chronic ITP: Improving quality of life and patient outcomes - touchSYMPOSIUM for touchHAEMATOLOGY 1:20:58

4M ago1:20:58

1:20:58

touchSYMPOSIUM for touchHAEMATOLOGY Listen to this touchSYMPOSIUM recorded live in December 2024 preceding the 66th American Society of Hematology Annual Meeting and Exposition in San Diego, CA, USA. Symposium chair Prof. Cindy Neunert is joined by Dr María Eva Mingot Castellano and Prof. David Kuter to discuss the impact of immune thrombocytopenia…

1
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchONCOLOGY 37:37

5M ago37:37

37:37

touchEXPERT FOCUS for touchONCOLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The expert…

1
Management of neurofibromatosis: Optimizing treatment and care from childhood to adult life - touchNEUROLOGY 37:38

5M ago37:38

37:38

touchEXPERT FOCUS for touchNEUROLOGY Listen to three experts provide insights into the optimal management of neurofibromatosis type 1 (NF1) in paediatric and adult patients, with a focus on plexiform neurofibromas (PNs). Strategies for ensuring the smooth transitioning of paediatric patients into the adult care system are also considered. The exper…

1
Advancing the treatment of muscle-invasive bladder cancer: Updates on immunotherapy in the perioperative setting 38:15

5M ago38:15

38:15

touchEXPERT OPINIONS for touchONCOLOGY Listen to an oncologist, urologist and oncology nurse highlight the key data for immunotherapy in the perioperative setting for muscle-invasive bladder cancer, practical considerations for its use in clinical practice, and how possible side effects can be monitored for and managed. They also consider the role …

1
Navigating treatment choices in high-risk early-stage melanoma - touchDERMATOLOGY 34:20

5M ago34:20

34:20

touchEXPERT OPINIONS for touchDERMATOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clini…

1
Navigating treatment choices in high-risk early-stage melanoma - touchONCOLOGY 34:19

5M ago34:19

34:19

touchEXPERT OPINIONS for touchONCOLOGY Listen to three leading experts in melanoma discuss the risk of recurrence in early-stage disease, evaluate the latest data for adjuvant and neoadjuvant therapies, and consider the role of emerging biomarkers for predicting recurrence and guiding treatment decisions. The experts Dr Tina J Hieken, Mayo Clinic, …

1
Advances in IOL technology and power calculations: Updates and innovations from 2024 13:58

6M ago13:58

13:58

touchFOCUS for touchOPHTHALMOLOGY Listen to Dr John Ladas, an expert in cataract surgery, as he answers a series of questions on intraocular lens power calculation, including how the use of artificial intelligence may help to improve accuracy, and provides an update on the latest advances in intraocular lens technology. The expert Dr John Ladas, Ma…

1
Supporting healing in epidermolysis bullosa: Innovations and new directions for care 18:55

6M ago18:55

18:55

touchFOCUS for touchDERMATOLOGY Listen to Prof. Amy Paller as she answers a series of questions on the key features of epidermolysis bullosa, including its pathophysiology and clinical manifestations. In addition, she responds to questions on the role of new and emerging topical therapies for epidermolysis bullosa in patient care, with a focus on a…

1
Primary biliary cholangitis: Appraising the changing therapeutic landscape 35:31

7M ago35:31

35:31

touchEXPERT OPINIONS for touchIMMUNOLOGY Listen to a leading expert in hepatology as they explore the current and future management of primary biliary cholangitis. The expert Dr Mitchell Shiffman - Bon Secours Liver Institute, Richmond, VA, USA This touchPODCAST is for HCPs only. This activity is funded by an independent medical educational grant f…

Podcasts Worth a Listen

TouchPODCAST

Podcasts Worth a Listen